Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing

Genome Engineering Synthetic Biology Guide RNA
DOI: 10.1016/j.molcel.2021.08.008 Publication Date: 2021-09-03T14:35:26Z
ABSTRACT
Compact and versatile CRISPR-Cas systems will enable genome engineering applications through high-efficiency delivery in a wide variety of contexts. Here, we create an efficient miniature Cas system (CasMINI) engineered from the type V-F Cas12f (Cas14) by guide RNA protein engineering, which is less than half size currently used CRISPR (Cas9 or Cas12a). We demonstrate that CasMINI can drive high levels gene activation (up to thousands-fold increases), while natural fails function mammalian cells. show has comparable activities Cas12a for activation, highly specific, allows robust base editing editing. expect be broadly useful cell therapy ex vivo vivo.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (41)
CITATIONS (275)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....